Ledger.Open graph →
SEC Form D · filed June 15, 2016

Lion Biotechnologies, Inc

Offering
$100.0M
Sold
$100.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Merrill Mcpeak · New York, NYDirectorSanford J. Hillsberg · New York, NYDirectorJay Venkatesan · Seattle, WADirectorMaria Fardis · New York, NYExec · DirectorMolly C. Henderson · New York, NYExecMichael T. Lotze · New York, NYExecSteven A. Fischkoff · New York, NYExecWayne J. Rothbaum · New York, NYDirectorRyan J. Maynard · New York, NYDirectorMolly C. Henderson · New York, NYExecMichael T. Lotze · New York, NYExecMerrill Mcpeak · SANTA MONICA, CADirectorSteven A. Fischkoff · New York, NYExecSanford J. Hillsberg · New York, NYDirectorJay Venkatesan · WOODLAND HILLS, CADirectorWayne J. Rothbaum · New York, NYDirectorMaria Fardis · New York, NYExec · DirectorRyan J. Maynard · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗